Detalhe da pesquisa
1.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Euro Surveill
; 29(13)2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551095
2.
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024.
Euro Surveill
; 29(15)2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38606570
3.
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Euro Surveill
; 28(4)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700868
4.
Establishing severe acute respiratory infection (SARI) surveillance in a sentinel hospital, Ireland, 2021 to 2022.
Euro Surveill
; 28(23)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289427
5.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveill
; 28(47)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997666
6.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Euro Surveill
; 28(47)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997665
7.
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Euro Surveill
; 27(21)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35620997
8.
Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
Epidemiol Infect
; 149: e157, 2021 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902786
9.
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
Euro Surveill
; 26(29)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296676
10.
Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020.
Euro Surveill
; 26(2)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446304
11.
High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020.
Euro Surveill
; 25(22)2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524949
12.
Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020.
Euro Surveill
; 25(26)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32643601
13.
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort.
Euro Surveill
; 24(48)2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796152
14.
Acute herpes zoster and post herpetic neuralgia in primary care: a study of diagnosis, treatment and cost.
Eur J Clin Microbiol Infect Dis
; 37(4): 627-631, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218466
15.
Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017.
Euro Surveill
; 22(14)2017 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424146
16.
Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Euro Surveill
; 21(7): pii=30139, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26924024
17.
I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
Euro Surveill
; 21(16)2016 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27124420
18.
Investigating incidence of and factors associated with SARS-CoV-2 infection over a nine-month period in a highly-vaccinated healthcare worker cohort.
QJM
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38759112
19.
Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
Vaccine
; 42(16): 3547-3554, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704257
20.
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Influenza Other Respir Viruses
; 18(1): e13243, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38204584